Substance P is involved in tumor progression in various types of cancers, in which, together with the NK-1 receptors from tumor cells, it increases proliferation, angiogenesis, metastasize, and inhibition of apoptosis through neurocrine, autocrine, or paracrine mechanisms [36,79,80,81]. Here, TACR1 is linked to cancer.